certify

Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

February 2, 2024 182 Views
EraCal Therapeutics Ltd. announced January 23rd it has entered into a collaboration and license agreement with Novo Nordisk ...
August 1, 2023 235 Views
The European Medicines Agency (EMA) is investigating Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s ...
June 14, 2023 280 Views
Novo Nordisk A/S and BIOCORP Production SA announced June 5th that Novo Nordisk has entered into exclusive negotiations ...
October 2, 2019 4190 Views
Novo Nordisk announced on September 20th U.S. Food and Drug Administration (FDA) approval for Rybelsus® (semaglutide) tablets 7 ...
banner
Adsense